|
| related topics |
| {stock, price, share} |
| {product, market, service} |
| {acquisition, growth, future} |
| {customer, product, revenue} |
| {provision, law, control} |
| {regulation, government, change} |
| {system, service, information} |
| {capital, credit, financial} |
| {personnel, key, retain} |
| {financial, litigation, operation} |
| {debt, indebtedness, cash} |
| {loss, insurance, financial} |
| {regulation, change, law} |
|
|
Risks Related to Our Business
Our revenues are dependent on expenditures by companies in the pharmaceutical and life sciences industries, and a variety of factors could cause the overall levels of those expenditures to decline.
Many of the contracts under which we provide services are subject to termination on short notice, which may make our revenues less predictable.
We are in the process of integrating a significant number of acquisitions and expect to make future acquisitions, which will involve additional risks
We may not be successful in managing our infrastructure and resources to support continued growth.
We employ sophisticated computer technology to deliver our services, and any failure of or damage to this technology could impair our ability to conduct our business.
We are subject to a high degree of government regulation.
Our services are subject to evolving industry standards and rapid technological changes
We may be adversely affected by customer concentration.
Substantial defaults by our customers on our accounts receivable could have a significant negative impact on our business, results of operations, financial condition or liquidity.
We may lose or fail to attract and retain key employees and management personnel.
We may incur liability in connection with litigation.
We may not be able to comply with the requirements of our credit facility.
Our future financial results may not be consistent with our guidance.
Risks Related to our Common Stock
The trading price of our common stock may be volatile, and you may not be able to sell your shares at or above the price at which you acquire them.
Anti-takeover provisions in our organizational documents make any change in control more difficult.
Our acquisition activity may dilute your equity interest and negatively affect the trading price of our common stock.
A substantial number of our securities are eligible for future sale and this could affect the market price for our stock.
Full 10-K form ▸
|
|
| related documents |
| 1089473--3/16/2006--VENTIV_HEALTH_INC |
| 1011432--3/31/2010--AUXILIO_INC |
| 1323639--3/31/2008--180_Connect_Inc. |
| 1047919--3/11/2009--AMBIENT_CORP_/NY |
| 1156388--3/16/2006--BIG_5_SPORTING_GOODS_CORP |
| 1126003--4/15/2009--ALTERNET_SYSTEMS_INC |
| 1070680--3/29/2010--CENTRAL_FEDERAL_CORP |
| 829117--4/10/2009--SAFE_TECHNOLOGIES_INTERNATIONAL_INC |
| 1140657--3/26/2008--HUNTINGTON_PREFERRED_CAPITAL_INC |
| 1182011--12/15/2010--FORCE_FUELS_INC. |
| 1024452--9/19/2008--SMF_ENERGY_CORP |
| 764402--2/28/2007--GREENE_COUNTY_BANCSHARES_INC |
| 764402--3/14/2006--GREENE_COUNTY_BANCSHARES_INC |
| 1310482--1/28/2010--Intelbahn_Inc. |
| 1220379--4/15/2008--Noble_Innovations_Inc |
| 1440819--11/25/2009--PAPERWORKS_INC. |
| 910638--2/24/2010--3D_SYSTEMS_CORP |
| 1080627--7/9/2008--GOLDEN_KEY_INTERNATIONAL_INC |
| 893816--3/15/2006--INFOCROSSING_INC |
| 850414--6/25/2007--NEW_HORIZONS_WORLDWIDE_INC |
| 1017526--9/28/2007--ACE_COMM_CORP |
| 1358099--3/25/2009--ROYAL_EQUINE_ALLIANCE_CORP |
| 893816--3/16/2007--INFOCROSSING_INC |
| 1292026--3/31/2010--Odimo_INC |
| 1292026--4/2/2007--Odimo_INC |
| 1099132--4/9/2010--MANHATTAN_SCIENTIFICS_INC |
| 351017--3/27/2008--AUTOINFO_INC |
| 1092302--3/16/2007--JAVO_BEVERAGE_CO_INC |
| 896429--9/28/2006--USA_TECHNOLOGIES_INC |
| 746834--3/13/2006--NGAS_Resources_Inc |
|